Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03328091 · ClinicalTrials.gov registry record · NA
Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 662
- Enrollment target
NCT03328091 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 662 participants.
The verdict
NCT03328091, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 662 participants
- Enrollment target
Study Summary
This randomized controlled trial aims to evaluate the impact of pre-test video education and post-test genetic counseling as compared to in-person pre-test genetic counseling in males with advanced prostate cancer.
Interventions
- OTHER Traditional pre-test genetic counseling
- OTHER Pre-test video education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 662 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2020-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03328091
The ClinicalTrials.gov registry entry for NCT03328091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 662 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Traditional pre-test genetic counseling is the first listed.
NCT03328091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03328091 about?
NCT03328091 is a clinical study titled "Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)". This randomized controlled trial aims to evaluate the impact of pre-test video education and post-test genetic counseling as compared to in-person pre-test genetic counseling in males with advanced prostate cancer.
What is the current status of trial NCT03328091?
This trial is currently completed. It is a NA study. The enrollment target is 662 participants. The study started on 2017-11-21. Estimated completion is 2020-02-13.
What interventions are being tested in trial NCT03328091?
The interventions under investigation include: Traditional pre-test genetic counseling (OTHER), Pre-test video education (OTHER).
Who is sponsoring clinical trial NCT03328091?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.